Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease

Philip Giffard, Steven Y C Tong, Deborah Holt, Anna Ralph, Bart Currie

    Research output: Contribution to journalArticle

    27 Downloads (Pure)

    Fingerprint Dive into the research topics of 'Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease'. Together they form a unique fingerprint.

    Medicine & Life Sciences